ROBERTI GLOBAL (F/K/A ROBERTI WHITE, LLC) for PFIZER INC.
Versions of this report
Every filing the register holds for this firm, client and period, oldest first. The most recent one is the version LegiList counts.
| Filing | Filed | Amount | Counted |
|---|---|---|---|
| 3rd Quarter - Report | Oct 21, 2019 | $80,000 | Replaced |
| 3rd Quarter - Amendment (this page) | Jan 22, 2020 | $80,000 | Yes |
What was lobbied
5 issue areas, each in the filer's own words, with who lobbied on it and where.
Trade (domestic/foreign) TRD
Issues involving international trade, including IP protections
| Lobbyist | Covered position, as disclosed |
|---|---|
| STEVEN E IRIZARRY | — |
| VINCENT A. ROBERTI, SR. | — |
Medicare/Medicaid MMM
Issues related to Medicare Part B, generally Issues related to Medicare Part D, including program restructuring, rebate reform, and beneficiary out-of-pocket costs Value-based payment arrangements
| Lobbyist | Covered position, as disclosed |
|---|---|
| STEVEN E IRIZARRY | — |
| VINCENT A. ROBERTI, SR. | — |
Copyright/Patent/Trademark CPT
Creating and Restoring Equal Access to Equivalent Samples (CREATES) Act (S. 340/H.R. 965)
| Lobbyist | Covered position, as disclosed |
|---|---|
| STEVEN E IRIZARRY | — |
| VINCENT A. ROBERTI, SR. | — |
Health Issues HCR
Issues related to drug pricing and value, generally, including the HHS Blueprint to Lower Drug Prices and Reduce Out-of-Pocket Costs. Issues related to biosimilars, generally Rebate reform, patient out-of-pocket costs, and value-based payment arrangements, generally.
| Lobbyist | Covered position, as disclosed |
|---|---|
| STEVEN E IRIZARRY | — |
| VINCENT A. ROBERTI, SR. | — |
Taxation/Internal Revenue Code TAX
- Issues related to international tax reform
| Lobbyist | Covered position, as disclosed |
|---|---|
| STEVEN E IRIZARRY | — |
| VINCENT A. ROBERTI, SR. | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.